BPK Bespak

RNS Number:0257C
Bespak PLC
26 April 2006


For immediate release                                              26 April 2006

                                   Bespak plc
                                ('the Company')

                            Chairman's Share Purchase


Bespak plc (LSE: BPK), a leader in specialty medical devices, reports that John
Robinson, Chairman of Bespak, has purchased 5,000 Ordinary shares of 10p each in
the Company at 589.5p per share.

John Robinson has increased his stake in Bespak plc to 8,000 shares or 0.0285%
of the Company's issued share capital.  The transaction was completed on Monday
24th April 2006 in fulfilment of John Robinson's obligations under Disclosure
Rule 3.1.2R; and Section 324 (as extended by section 328 of the Companies Act
1985.

                                      ENDS


For further information please call:

Bespak plc
Mark Throdahl - Chief Executive                          +44 (0) 20 1908 552 600
Martin Hopcroft - Group Finance Director

Buchanan Communications                                     +44 (0) 20 7466 5000
Tim Thompson / Mark Court / Mary-Jane Johnson


Notes for Editors:


About Bespak plc

Bespak, a leader in specialty medical devices, develops delivery systems for the
pharmaceutical industry and disposable airway management products for critical
care settings.  Bespak's product range includes metered dose and dry powder
inhalers, actuators, inflation valves, disposable face masks, breathing circuits
and laryngeal tubes.  The group, which has facilities in King's Lynn and Milton
Keynes in the UK and Indianapolis and Kent, Ohio, in the US, is quoted on the
Official List of the London Stock Exchange (LSE: BPK).  For more information,
please visit www.bespak.com.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RDSLQLFLQZBBBBB

Bespak (LSE:BPK)
Historical Stock Chart
From Jun 2024 to Jul 2024

Bespak (LSE:BPK)
Historical Stock Chart
From Jul 2023 to Jul 2024